Search

You searched for "disease"

2385 results found
Ocular immunology and inflammation journal cover image.

Three years of experience with quantiferon-TB Gold Testing in patients with uveitis

1 April 2015 | | EYE - Vitreo-Retinal
Quantiferon-TB Gold is a new alternative to the tuberculin skin test that utilises synthetic peptides representing M. tuberculosis antigens ESAT-6, CFP-10, TB7.7 and upon incubation with whole blood IFN-γ is released from pre-sensitised T cells and can be measured by...
Neuro-Ophthalmology journal cover image

Can coenzyme Q10 have a protective role in ethambutol-induced retinal ganglion cell toxicity

3 April 2023 | | EYE - Neuro-ophthalmology | Ethambutol, coenzyme Q10, ethambutol toxic optic neuropathy, retinal ganglion cells, tuberculosis
Tuberculosis (TB) is one of the most prevalent infectious diseases, especially in developing or low- income countries. Ethambutol is a widely used drug to treat TB. Ethambutol can cause visual disturbance including ethambutol toxic optic neuropathy (ETON). ETON is one...
Experimental Eye Research cover image.

Nanoparticle administration of latanoprost

1 December 2013 | | EYE - Glaucoma
Glaucoma is a progressive optic neuropathy characterised by increased ocular pressure and loss of retinal ganglion cells. Conventional drug therapy with eye drops to reduce intraocular pressure (IOP) has variable bioavailability and can lead to ocular surface disease. In this...

A semi-automated algorithm for identifying glaucoma patients with blindness

2 October 2025 | | EYE - Glaucoma
Patients with sight impairment (previously referred to as partial sightedness) or severe sight impairment (previously referred to as blindness) are eligible for a certificate of visual impairment (CVI). Certification confers eligibility for a wide range of benefits administered by local...

The screening and treatment of retinopathy of prematurity

1 December 2013 | | EYE - Paediatrics, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
A male child is born at 31 weeks and requires 100% oxygen supplementation with intensive care. What would be the ophthalmic management of this child? In the first instance, it will be useful to know the screening criteria and protocol....

An interview with Professor John Forrester

2 December 2019 | | EYE - General
What made you choose ophthalmology as a career and how did your interest in academia develop? During Medical School at Glasgow University, I was getting progressively disillusioned with the career options while my colleagues and friends all seemed to quickly...

In conversation with John Forrester

2 December 2019 | | EYE - General
What made you choose ophthalmology as a career and how did your interest in academia develop? During Medical School at Glasgow University, I was getting progressively disillusioned with the career options while my colleagues and friends all seemed to quickly...

Scottish universities transform eye health research with retinal imaging resource

28 October 2025 | imaging, SCONe, AI, research, technology
Retinal imaging network achieves millionth image milestone in fight against diseases. A Scottish research initiative which set out to safeguard retinal images for innovation in eye research has reached a major milestone. Having secured over one million retinal images since...

Eye research: where next?

1 December 2017
Eye research in the UK is underfunded relative to other areas of medical research and general awareness of sight loss and its prevention remains poor, messages that were reinforced in presentations and discussions during a recent research summit meeting in...

In conversation with Dr Monicah Bitok, Global Inclusive Eye Health Advisor (CBM)

22 April 2022 | EYE - General
Eye News spoke to Dr Monicah Bitok, Global Inclusive Eye Health Advisor with the Christian Blind Mission (CBM), about the rise in diabetes-related preventable blindness, systemic ophthalmic changes in low- and middle-income countries, and the impacts of a COVID-19-induced backlog...

Corporate M&A pace gathers momentum

1 October 2019 | | EYE - General
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...

CRATER 2025

8 October 2025 -10 October 2025
The Conference on Recent Advances in Translational Eye Research 2025